SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of West Pharmaceutical Services
1. Faruqi & Faruqi investigating claims against West Pharmaceutical Services. 2. Investors with losses over $100,000 between February 2023 and 2025 encouraged to join. 3. Allegations include false statements and significant destocking issues in high-margin products. 4. West's stock dropped 38% after reveals about weak earnings forecasts. 5. Deadline for lead plaintiff application in class action is July 7, 2025.